MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Synthetic Biologics Company Profile (NYSE:SYN)

Consensus Ratings for Synthetic Biologics (NYSE:SYN) (?)
Ratings Breakdown: 1 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $5.25 (110.00% upside)

Analysts' Ratings History for Synthetic Biologics (NYSE:SYN)
Show:
DateFirmActionRatingPrice TargetActions
8/25/2015BTIG ResearchInitiated CoverageBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/23/2015Griffin SecuritiesReiterated RatingBuy$6.75 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/4/2015HC WainwrightSet Price TargetBuy$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015William BlairInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2015Maxim GroupDowngradeBuy -> Hold$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2015Maxim GroupLower Price TargetBuy$6.00 -> $3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/19/2014Maxim GroupBoost Price TargetBuy$3.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/17/2013Noble FinancialInitiated CoverageBuy$3.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/30/2013Maxim GroupInitiated CoverageBuy$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 9/1/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha